4상완료
Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder
연구 개요
Because the bladder neck and proximal urethra contain abundant α1-adrenergic receptors, α-blockers or α1-blockers are well-known to reduce bladder neck obstruction in patients with or without neurogenic bladder. α1-blockers seem to have a potential to reduce bladder outlet resistance during voiding in patients with neurogenic bladder. Based on these turnouts, we designed this clinical study to evaluate the clinical effect and safety of silodosin on voiding dysfunction associated with neurogenic bladder.
- 스폰서
- 리드: JW중외제약
- 적응증
- Neurogenic Bladder, Voiding Dysfunction
- 중재
- silodosin
- 목표 등록
- 95명
- 시작일
- 2011-04-01
- 완료(예정)
- 2012-01-01
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.